Aura Biosciences Inc. , a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate therapies for multiple oncology indications, today announced that Elisabet de los. | May 12, 2023
ALACHUA, Fla. and TAMPA, Fla., May 12, 2023 Axogen, Inc. , a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Peter. | May 12, 2023
/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for.